You searched for dna - Page 35 of 40

News and Trends 2 Jul 2020

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

…and hemophilia A. The company will also expand its gene therapy manufacturing capacity. The company’s technology consists of delivering therapeutic DNA into patients via a viral vector. The technology has…

July 2, 2020 - 3 minutesmins - By Helen Albert

Opinion 12 Dec 2022

Artificial intelligence: a new era in rare genetic disease diagnosis

…data you feed it. Limitations arise in the form of non-coding pathogenic variants, ancestry-specific bias in genomic datasets and patient data protection issues. Non-coding variants are regions of the DNA sequence…

December 12, 2022 - 6 minutesmins - By External Contributor

News and Trends 28 Jul 2022

Mission Bio launches new cancer assay

…sensitivity and specificity of commercial MRD tests used today both in research and to predict cancer recurrence in patients, leveraging the Tapestri Platform’s ability to measure DNA and surface protein…

July 28, 2022 - 3 minutesmins - By Jim Cornall

Centogene Rare Disease Diagnostics Series A

News and Trends 13 Jun 2017

German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases

…as Shire, and recently entered a collaboration with US-based FDNA to support FDNA’s comprehensive database that combines phenotypic and genomic information associated with over 8,000 rare diseases and genetic disorders….

June 13, 2017 - 2 minutesmins - By Melanie De Almeida

Best in Biotech 10 Jun 2025

Pushing biotech forward in France: 18 companies to know about

…precise DNA modifications without introducing double-strand breaks. This approach aims to offer a safer and more efficient alternative to traditional gene-editing tools like CRISPR-Cas9. In April 2025, Brink secured $4…

June 10, 2025 - 16 minutesmins - By Jules Adam

elypta renal cell carcinoma kidney blood cancer

News and Trends 4 Feb 2019

Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test

…renal cell carcinoma that we know of,” Karl Bergman, CEO of Elypta, told me. While most blood and urine cancer tests detect genetic material such as DNA, Elypta measures the…

February 4, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 11 Nov 2022

Beyond Biotech podcast 22: PacBio, Sierra Space

…recently announced beta testing of its Onso Sequencing System. The benchtop short-read DNA sequencing platform is expected to provide a new level of accuracy by utilizing PacBio’s sequencing by binding…

November 11, 2022 - 3 minutesmins - By Jim Cornall

Radiopharmaceuticals for cancer therapy: interview with Steffen Schuster

Interview 17 Aug 2022

The challenges of developing radiopharmaceuticals for cancer

…are generating investor excitement, including immuno-oncology, DNA damage repair and protein degradation. Another emerging area with huge potential is the treatment of cancer using drugs that carry radioactive molecules, known…

August 17, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 22 Jun 2016

World’s first CRISPR Clinical trial has just been Approved!

…Cas9 DNA-splicer programmed by RNA strands in the CRISPR/Cas9 gene editing system. This clinical data is now one step closer to reality as the US National Institutes of Health (NIH)…

June 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 24 Oct 2019

British AI Firm Gets €9M Boost to Develop Drug-Discovery Tech

…CEO. EVA is an engine that has the ability to map the links between DNA sequence and the function of the corresponding proteins. It collects large amounts of data generated…

October 24, 2019 - 2 minutesmins - By Helen Albert

News and Trends 22 Jan 2018

European Court Supports the Softening of CRISPR Gene Editing Rules

…genes or pieces of DNA from other species was against EU law. However, the directive allowed mutagenesis techniques like irradiation, and confusion grew. Many breeders felt that gene editing should…

January 22, 2018 - 3 minutesmins - By Alex Dale

glioblastoma oncolytic virus transgene 2

News and Trends 20 Sep 2022

Collaboration to develop new glioblastoma combination therapy nets €1.06M

…production by using DNA immunization is vital to the project. “We are excited to bring our extensive expertise in antibody engineering to the OpSIS project. Additionally, our platforms in molecular…

September 20, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: dna

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

Artificial intelligence: a new era in rare genetic disease diagnosis

Mission Bio launches new cancer assay

German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases

Pushing biotech forward in France: 18 companies to know about

Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test

Beyond Biotech podcast 22: PacBio, Sierra Space

The challenges of developing radiopharmaceuticals for cancer

World’s first CRISPR Clinical trial has just been Approved!

British AI Firm Gets €9M Boost to Develop Drug-Discovery Tech

European Court Supports the Softening of CRISPR Gene Editing Rules

Collaboration to develop new glioblastoma combination therapy nets €1.06M

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!